No Detail Found!

Sinopharm and Sinovac COVID-19 vaccines; Prevalence and risk factors for post full vaccination weak immunity.

Author(s)
Sahibzada Syed Masood us Syed Sialkot Medical College (SMC), Sialkot, Pakistan
Abid Ali Ranjha Community Medicine, Sialkot Medical College (SMC), Sialkot, Pakistan
Sidra Ghazanfer Khawaja Muhammad Sader Medical College, Sialkot, Pakistan
Syed Muhammad Shah Hussain Miran Usman General Hospital, Sialkot, Pakistan
Syeda Zahra Najam Sialkot Medical College (SMC), Sialkot, Pakistan
Syeda Kainat Fatima Sialkot Medical College (SMC), Sialkot, Pakistan
Hassan Osman Muhmood Director Colonel Sultan’s Lab, Sialkot, Pakistan
Hamda Saqib Imran Idrees Teaching Hospital, Sialkot, Pakistan
Abstract
Objective: To see the prevalence and risk factors for post full vaccination (Sinopharm and Sinovac COVID-19 vaccines) weak immunity in persons with no history of viral exposure. Study Design: Prospective Observational. Setting: Syed Research Centre, Sialkot. Period: Nov 2021 to Feb 2022. Material & Methods: Eighty two individuals (male/female, aged: 24-70 years) were enrolled from District Sialkot (Pakistan). Two doses of Sinopharm or Sinovac COVID-19 vaccine were administered to each participant before blood sampling. The quantity of COVID-19 spike immunoglobulin G against SARS-CoV-2 (5-Antigen) was detected in serum using chemiluminescence immunoassay technique [threshold titer: 7.1 (detection), 105. 63 (seroprotection), 492.96 BAU/mL (strong humoral response)]. Results: Overall, 96.3% seropositivity, 89% seroprotection, and 37.8% (n = 31) weak immune response were recorded. Whereas, mean antibody titer was found to be 2312.02 (range: 0.0 - 28711.74) BAU/mL. A vaccinated male had approximately 4 folds (95%CI: 1.297 - 11.504; p = .002) more likelihood of weak immune response than females. Similarly, the rate of poor immunological outcome was higher in individuals with >24.9 Kg/m2 (69.2%, n = 27) body mass index compared to =24.9 Kg/m2. A person with Sinopharm COVID-19 vaccine was more vulnerable to weak immune response than Sinovac vaccinated participants (RR = 2.351; 95%CI = 1.327 - 4.167; p .002; 57.6% vs. 24.5%, respectively). Co-occurrence of age (>47 years) and BMI (>24.9 Kg/m2) existed in 11 of 28 males (39.3%) with impaired immunogenicity. Conclusion: The high rate of post full vaccination weak immune response is alarming. Gender, BMI, and vaccine type were amongst the predictors for diminished humoral response.
Publication Details
Page(s) 1486-1492
DOI DOI not available
Published Journal: Professional Medical Journal, Volume: 29, Issue: 10, Year: 2022

Request the full text from PASTIC

Keywords
prevalence, Immunoglobulin G, Body mass index, Risk factors., COVID-19 Vaccines
0

Citations

0

Downloads

20

Views